Conquering Design Challenges in the Construction of Immunomedics’ Multiproduct Cell Culture Bioreactor Facility

by Jeng-Dar Yang, PhD, Carl Sharo, Grant Merrill, and Cynthia Sullivan
Volume 5, Issue 3 (Fall 2006)

In the last few years, we have seen many biotech products approved by FDA. These products have gained public awareness because of their ability to treat several debilitating diseases with very minimal side effects, and thereby impact the quality of life for many people. As a result, the biotech industry is constantly in the news for its successes and programs to develop new therapeutics for many unmet medical needs. Immunomedics, Inc., a New Jersey biotechnology company, recently completed an expansion project that included new bioreactor manufacturing suites and support laboratories. Building on the company’s existing headquarters site and fully integrating the new capacity into the existing operational facility, the project spanned two years and was completed in 2003…

Citation:
Yang J, Sharo C, Merrill G, Sullivan C. Conquering Design Challenges in the Construction of Immunomedics’ Multiproduct Cell Culture Bioreactor Facility. BioProcess J, 2006; 5(3): 15-23. https://doi.org/10.12665/J53.Yang